Clinical Trials Browser

Phase 3 × Unknown × Brentuximab Vedotin × Clear all

NCT06186986 2024-01-02

CD30 Imaging in Diffuse Large B-cell Lymphoma

Phase 3 Unknown

Dendritic Cell Sarcoma, Interdigitating